Kruse Nils, Neumann Katrin, Schrage Arnhild, Derkow Katja, Schott Eckart, Erben Ulrike, Kühl Anja, Loddenkemper Christoph, Zeitz Martin, Hamann Alf, Klugewitz Katja
Medical Clinic I, Charité Campus Benjamin Franklin, Berlin, Germany.
Hepatology. 2009 Dec;50(6):1904-13. doi: 10.1002/hep.23191.
Elucidating cellular mechanisms that maintain the intrahepatic immune balance is crucial to our understanding of viral or autoimmune liver diseases and allograft acceptance. Liver sinusoidal endothelial cells (LSECs) play an important role in modifying local immune responses to tolerance in major histocompatibility complex (MHC) I-restricted models, whereas their contribution in the MHCII context is still controversial. In an MHCII chimeric mouse model that excludes MHCII-mediated antigen presentation by professional antigen-presenting cells, we demonstrated that LSECs prime CD4(+) T cells to a CD45RB(low) memory phenotype lacking marker cytokine production for effector cells that was stable in vivo following immunogenic antigen re-encounter. Although these cells, which we term T(LSEC), had the capacity to enter lymph nodes and the liver, they did not function as effector cells either in a delayed-type hypersensitivity reaction or in a hepatitis model. T(LSEC) inhibited the proliferation of naïve CD4(+) T cells in vitro although being CD25(low) and lacking expression of forkhead box protein (FoxP)3. Furthermore, these cells suppressed hepatic inflammation as monitored by alanine aminotransferase levels and cellular infiltrates in a T cell-mediated autoimmune hepatitis model in vivo.
T(LSEC) first described here might belong to the expanding group of FoxP3(-) regulatory T cells. Our findings strengthen the previously discussed assumption that CD4(+) T cell priming by nonprofessional antigen-presenting cells induces anti-inflammatory rather than proinflammatory phenotypes. Because recruitment of CD4(+) T cells is increased upon hepatic inflammation, T(LSEC) might contribute to shifting antigen-dependent immune responses to tolerance toward exogenous antigens or toward endogenous self-antigens, especially under inflammatory conditions.
阐明维持肝内免疫平衡的细胞机制对于我们理解病毒性或自身免疫性肝病以及同种异体移植物的接受至关重要。肝窦内皮细胞(LSECs)在主要组织相容性复合体(MHC)I限制模型中调节局部免疫反应以诱导耐受性方面发挥重要作用,而它们在MHCII环境中的作用仍存在争议。在一个排除专业抗原呈递细胞介导的MHCII抗原呈递的MHCII嵌合小鼠模型中,我们证明LSECs将CD4(+) T细胞诱导为CD45RB(low)记忆表型,缺乏效应细胞的标记细胞因子产生,在再次遇到免疫原性抗原后在体内稳定。尽管这些我们称为T(LSEC)的细胞有能力进入淋巴结和肝脏,但它们在迟发型超敏反应或肝炎模型中均未发挥效应细胞的功能。T(LSEC)在体外抑制幼稚CD4(+) T细胞的增殖,尽管其CD25(low)且缺乏叉头框蛋白(FoxP)3的表达。此外,在体内T细胞介导的自身免疫性肝炎模型中,通过丙氨酸转氨酶水平和细胞浸润监测发现这些细胞抑制肝脏炎症。
此处首次描述的T(LSEC)可能属于不断扩大的FoxP3(-)调节性T细胞群体。我们的发现强化了之前讨论的假设,即非专业抗原呈递细胞引发的CD4(+) T细胞诱导抗炎而非促炎表型。由于肝脏炎症时CD4(+) T细胞的募集增加,T(LSEC)可能有助于将抗原依赖性免疫反应转变为对外源抗原或内源性自身抗原的耐受性,尤其是在炎症条件下。